Have or know a teenager in school? A controversial government sponsored program called ‘TeenScreen’ asks your kid a few questions and determines if they are a suicide risk or not. A high percentage winds up on psychicatric drugs. Fred A. Baughman Jr., MD testifies for State of Georgia about this.
If, after reading this, you’d like to sign a petition to end this kind of B.S., follow this link.
Testimony to the State of Georgia Senate
Re: Senate Bill 430-TeenScreen
by Fred A. Baughman Jr., MD
August 16, 2006
Whether you speak of teen-screen, infant-screen, toddler-screen or elder- screen (they are all on their way to the nearest school), there is one thing you need to know about psychiatric diagnosis: there is no such thing as a psychiatric “disorder,” “disease,” or, “chemical imbalance.” And yet, psychiatry, Big Pharma, the House, Senate and White House, drunk on money and power, insist that all psychiatric diagnoses are “diseases” which must be treated, if even by court order; if even they have to call you a “negligent” parent and make the court your child’s parent.
We continue to accept the “chemical imbalance” lie at our own peril. Infinite damage has already been done. Think Columbine, think Conyers, Georgia, where T.J. Solomon shot six, think Haditha, Iraq, and think of the Armed Forces recruiting shortfalls due to the burgeoning psychiatric epidemic in the nation’s schools. Think of the accumulative toll of our believing in this brazen, Machiavellian, lie. Think of a child in your own family (like classrooms, every family has one-or more).
In 1948, psychiatry and neurology were made into separate specialties- neurology, my specialty, to diagnose and treat actual diseases of the brain; psychiatry to address the emotional and behavioral (psychological) problems in normals, and, in the physically ill as well-none of them diseases. 
In the fifties, chlorpromazine/Thorazine, the first antipsychotic drug was synthesized. Other psychotropic drugs followed. Today, 91% of children who see a child psychiatrist are put on a drug, 18% –most of them normal–on a dangerous, deadly, antipsychotic.
In 1960, when I graduated from the NYU School of Medicine, no such thing as a psychiatric disease existed.
In 1963 when I was the first to analyze the chromosomes of cancer cells from the spinal fluid  and in 1969 when I was the first to describe glioma- polyposis syndrome (another word for disease)  there was still no such thing as a psychiatric disease-a disease being a demonstrable macroscopic, microscopic, or chemical abnormalities-a palpable or visible tumor, a positive “Pap” smear or biopsy, or, an elevated blood sugar as in diabetes mellitus or phenylalanine level, in PKU.
Little did I know that Psychiatry, Big Pharma and the Federal Government were well along with their “big lie,” marketplace strategy–to tell the public-all patients at one time or another, that emotional and behavioral problems were not due to their upbringing, environment, circumstances, but that-eureka!– they were “disorders”/ “diseases”/ “abnormalities” /”chemical imbalances” of the brain, each needing, or requiring, a chemical balancer–pill.
On September 29, 1970, Representative Cornelius Gallagher of New Jersey launched the Congressional hearing, Federal Involvement in the Use of Behavior Modification Drugs on Grammar School Children: Behavior Modification Drugs in School Children, saying: “I have received letters critical of minimal brain dysfunction, one of thirty-eight names attached to this condition.”
But, clearly, the “chemical imbalance” strategy was in place. Dr. Ronald Lipman, Chief of the Clinical Studies Section, FDA, testified: “…hyperkinesis is a medical syndrome. It should be properly diagnosed by a medical doctor.”
In the DSM-III of 1980 it was ADD; in the DSM-III-R of 1987, ADHD; in the DSM- IV of 1994, it was ADHD of another sort. No science to get in the way.
On December 22, 1994, Paul Leber, MD, Director, Division of Neuropharmacological Drug Products of the FDA, wrote to me: “… no distinct pathophysiology for the disorder (ADHD) has been delineated.”
On May, 13, 1998, F. Xavier Castellanos of the NIMH wrote to me: “… we have not yet met the burden of demonstrating the specific pathophysiology that we believe underlies this condition.”
At the November 16-18, 1998 Consensus Conference, William B Carey , speaking on the subject: “Is ADHD a Valid Disorder?” concluded: “What is…described as ADHD in the United States appears to be a set of normal behavioral variations…”
James M. Swanson and F. Xavier Castellanos  reviewed the structural/anatomic MRI research [5-18] concluding: “… ADHD subjects have on-average 10% brain atrophy.”
From a floor microphone I (Baughman) challenged Swanson: “Why didn’t you mention that virtually all of the ADHD subjects were on stimulant (Ritalin, Dexedrine, Adderall) therapy and that this is the likely cause of their brain atrophy?”
With their main line of evidence shown to be a lie, the Consensus Conference Panel confessed: ” …we do not have an independent, valid test for ADHD…there are no data to indicate that ADHD is a brain malfunction.”
Palco of NPR observed: “ADHD is like the Supreme Court’s definition of pornography: ‘You know it when you see it.'”
On October 9, 2002, Castellanos, et al , published the one-and-only MRI study of an ADHD-untreated group. Inexplicably, they failed to use matched controls. This voided the study. ADHD remained without validation as a disease while the ADHD drugs-methylphenidates and amphetamines remained the probable cause of the “on-average, 10 percent” brain atrophy.
In 2002, Weinberger  of the NIMH claimed “major psychiatric diseases”…are associated with “subtle but objectively characterizable changes.” However, he could not reference proof that a single psychiatric “disease” actually exists.
In 2002, the Advertisement Commission of Holland determined that Brain Foundation-Holland claim that ADHD is an inborn brain dysfunction “…gives a wrong and misleading representation and enjoined them to stop.
In 2003, Ireland prohibited GSK (GlaxoSmithKline) from claiming on it’s Paxil/paroxetine leaflet: “(it) works by bringing serotonin levels back to normal.”
While the FDA’s Goodman , acknowledged that claims that SSRIs correct a serotonin imbalance go “too far,” he lied every bit as much, suggesting: “this is reasonable shorthand for expressing that this is a chemically or brain- based problem.”
Saying any psychiatric diagnosis “… is a brain-based problem and that the medications are normalizing function,” is an anti-scientific, pro-drug, lie- one that reflects FDA and government policy generally.”
There is nothing more despicable than a physician who knowingly tells normal patients that they are “sick,” “ill,” or “diseased,” for profit. Yet this has become standard practice throughout medicine, and at the Food and Drug Administration (FDA), American Psychiatric Association (APA), American Medical Association (AMA), American Academy of Child and Adolescent Psychiatry (AACAP), American Academy of Pediatrics (AAP), American Academy of Neurology (AAN), Child Neurology Society (CNS), American Academy of Family Practice (AAFP), and countless other organizations.
All health care agents and agencies, and all manufacturers of drugs must cease their representations of psychological/psychiatric diagnoses as diseases/ “chemical imbalances.” The right to informed consent–universally abrogated by such lies–must be restored to US medicine.
Because psychiatric patients are physically/medically normal but are called “diseased” their right to informed consent has been revoked.
Because those made into “patients” are known to normal to begin with, those who “treat” them actually poison them and are guilty, not of an iatrogenic medical mistake, but of willful, for-profit poisoning-a felony.
What are we to call it when children die pursuant to a fraudulent diagnosis, such as ADHD, such as the 186 known to have died from methylphenidate/Ritalin, between 1990 and 2000? First degree murder? Second degree murder? Justifiable homocide? Manslaughter?
From 1970 to the present, thirty-six years–the House, Senate and White House have accepted (with a nod and wink) the “disease” lie/perjury from representatives of the Psychiatry-Big Pharma cartel, have embraced it, and have authorized and funded (with our hard-earned tax) billions for the research, diagnosis and treatment of “diseases” that do not exist, conferring upon them the only hint of legitimacy they would ever have. So doing, our Federal Government has become the third, essential member of the Psychiatry- Big Pharma-US Federal Government cartel.
Our Federal Government is no longer free commit to our health and well-being.
FRED A. BAUGHMAN, JR. M.D.
NEUROLOGY AND CHILD NEUROLOGY (Board Certified)
FELLOW, AMERICAN ACADEMY OF NEUROLOGY
Author: The ADHD Fraud-How Psychiatry Makes “Patients” of Normal Children
1303 HIDDEN MOUNTAIN DRIVE, EL CAJON, CA 92019, U.S.A.
1. Cohen MM, editor. American Academy of Neurology: The first 50 years, 1948- 1998 p 1-8. (1998). St. Paul (Minnesota): American Academy of Neurology.
2. Baughman, F. A., Jr., Hirsch, B.: Karyotyping of Cells from Cerebrospinal Fluid (letter). Lancet. 1963; 2:417.
3. Baughman, F. A., Jr., List, C. F., Williams, J. R., Muldoon, J. P., Segarra, J. M.: The Glioma-Polyposis Syndrome. New England Journal of Medicine, 281:1345-1346, 1969.
4. Carey, WB. NIH Consensus Conference on ADHD, November 16-18, 1998.
5. Swanson J, Castellanos FX. Biological Bases of Attention Deficit Hyperactivity Disorder. NIH Consensus Development Conference on ADHD (p 37-42, program and abstracts), November 16-18, 1998, National Institutes of Health, Bethesda, MD
6. Developmental Trajectories of Brain Volume Abnormalities in Children and Adolescents With Attention- Deficit/Hyperactivity Disorder F. Xavier Castellanos, Patti P. Lee, MD; Wendy Sharp, MSW; Neal O. Jeffries, PhD; Deanna K. Greenstein, PhD; Liv S. Clasen, PhD; Jonathan D. Blumenthal, MA; Regina S. James, MD; Christen L. Ebens, BA; James M. Walter, MA; Alex Zijdenbos, PhD; Alan C. Evans, PhD; Jay N. Giedd, MD; Judith L. Rapoport, MD JAMA. 2002;288:1740-1748.
7. Weinberger DR. In “Imaging for psychiatric disorders is done mainly for research, not clinical purposes,” Neurology Today, June, 2002.
8. Wayne K. Goodman, MD Chair of the US Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee, quoted in Canadian Medical Association Journal, March 14, 2006. SSRI ads questioned. Colin Meek. Wester Ross, ScotlandÂ